Skip to main content

Disclaimer

In the Downloads section, the ‘Prior Submission’ file reflects the most recent measure submission to the former CBE. This file is provided for transparency. For any questions or clarification, please contact the designated measure steward.

Heart Failure - Use of Beta Blocker Therapy

CBE ID
0615
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

The percentage of patients 18 years and older diagnosed with heart failure who are taking a beta blocker

    Measure Specs
      General Information
      1.14 Numerator

      Patients with a current fill for beta blocker therapy

      1.15 Denominator

      Percentage of patients 18 years and older diagnosed with heart failure

      Exclusions

      SPECIFIC EXCLUSIONS:
      Contraindications to a beta blocker, including:
      - Asthma
      - COPD
      - Bradycardia
      - Hypotension
      - Aortic stenosis
      - Peripheral artery disease medications
      - Heart block in the absence of a pacemaker
      - Cocaine abuse
      - Pulmonary hypertension medications
      - Heart transplant
      -Heart valve surgery
      - Patient or provider feedback indicating allergy,intolerance or contraindication to the drug anytime in the past

      GENERAL EXCLUSIONS:
      •Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months;
      •Patients who have been in a skilled nursing facility in the last 3 months
      •Patients who are terminally ill or in a hospice

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative Data
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      ActiveHealth Management
      Steward POC email
                Public Comments